Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SCHIZOPHRENIA 1 (Disorder)”

138 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 138 results

Early research (Phase 1)Looking for participantsNCT07230652
What this trial is testing

MAD Study to Evaluate the Safety and Tolerability of LY03020

Who this might be right for
SchizophreniaAlzheimer's Disease Psychosis
Luye Pharma Group Ltd. 40
Post-approval studies (Phase 4)Study completedNCT00524043
What this trial is testing

An Efficacy and Safety Study of One Dosage of Paliperidone Extended Release (ER) in Treating Patients With Schizophrenia

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 201
Not applicableStudy completedNCT00155506
What this trial is testing

Molecular Genetic Study of Schizophrenia: Parent-Offspring Trios

Who this might be right for
Schizophrenia
National Taiwan University Hospital 600
Early research (Phase 1)Study completedNCT01429740
What this trial is testing

The Safety, Tolerability And Pharmacokinetics Of Single Doses Of PF-05180999 In Healthy Adults

Who this might be right for
Schizophrenia
Pfizer 29
Not applicableStudy completedNCT05603260
What this trial is testing

Imagery Interventions for Auditory Vocal Hallucinations

Who this might be right for
Auditory HallucinationHearing Voices When No One is TalkingPsychosis
Hella Janssen 32
Early research (Phase 1)Study completedNCT01774435
What this trial is testing

Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane Implant

Who this might be right for
Schizophrenia
Endo Pharmaceuticals 35
Early research (Phase 1)Study completedNCT04787302
What this trial is testing

PET Trial to Evaluate Target Occupancy of CVL-231 on Brain Receptors Following Oral Dosing

Who this might be right for
Schizophrenia
Cerevel Therapeutics, LLC 15
Post-approval studies (Phase 4)Not Yet RecruitingNCT07213466
What this trial is testing

Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder

Who this might be right for
Bipolar I DisorderBipolar II DisorderSchizo Affective Disorder+3 more
Mayo Clinic 100
Not applicableUnknownNCT01075373
What this trial is testing

A Neurobiological Study on Heterogeneity of Schizophrenia: Genetic Variations and Neurobiological Differentiations

Who this might be right for
Schizophrenia
National Taiwan University Hospital 360
Early research (Phase 1)Study completedNCT01209039
What this trial is testing

A Repeat Dose Positron Emission Tomography Study With GSK1144814

Who this might be right for
Schizophrenia
GlaxoSmithKline 41
Large-scale testing (Phase 3)Not Yet RecruitingNCT07084831
What this trial is testing

A Prospective, Open-label, Single-arm, Multicenter Study Evaluating the Efficacy of One Year Treatment With Xanomeline/Trospium on Cognitive Impairment in Clinically Stable Adult Participants With Schizophrenia.

Who this might be right for
Schizophrenia; PsychosisCognitive Impairment
European Group for Research In Schizophrenia 171
Early research (Phase 1)Study completedNCT00791232
What this trial is testing

Extended Release Extended-release (ER) OROS Paliperidone Tolerability, as Compared to Immediate-release (IR)Risperidone, in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 113
Large-scale testing (Phase 3)Study completedNCT00297388
What this trial is testing

How Long it Takes a Patient to Relapse After Switching From an Oral Antipsychotic to One of Two Doses of Long-acting Risperidone Injections in Patients With Schizophrenia or Schizoaffective Disorder

Who this might be right for
SchizophreniaSchizoaffective Disorder
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 40
Testing effectiveness (Phase 2)Study completedNCT01348100
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of Iloperidone Depot in Schizophrenic Patients

Who this might be right for
Schizophrenia
Novartis Pharmaceuticals 81
Early research (Phase 1)Study completedNCT02748694
What this trial is testing

Phase 1 TAK-041 First-in-Human Safety, Tolerability, and Pharmacokinetics Study

Who this might be right for
Healthy VolunteersSchizophrenia
Neurocrine Biosciences 114
Testing effectiveness (Phase 2)Study completedNCT04457310
What this trial is testing

A Translational and Neurocomputational Evaluation of a Dopamine Receptor 1 Partial Agonist for Schizophrenia

Who this might be right for
Early Course Schizophrenia Spectrum Disorder
Yale University 112
Early research (Phase 1)Study completedNCT01457339
What this trial is testing

Assess the Safety and Pharmacokinetics of Ascending, Multiple Oral Doses of SPD489 in Adults With Schizophrenia

Who this might be right for
Schizophrenia
Shire 31
Not applicableLooking for participantsNCT06740383
What this trial is testing

Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services

Who this might be right for
Schizophrenia Spectrum and Other Psychotic DisordersSchizophreniaDelusional Disorder+4 more
Beth Israel Deaconess Medical Center 320
Testing effectiveness (Phase 2)Study completedNCT00218218
What this trial is testing

Effects of Transdermal Nicotine on Smoking, Craving and Withdrawal in People With Schizophrenia

Who this might be right for
Schizophrenia and Disorders With Psychotic FeaturesTobacco Use DisorderSchizophrenia
National Institute on Drug Abuse (NIDA) 48
Early research (Phase 1)Study completedNCT03370640
What this trial is testing

Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Japanese Male and Female Subjects With Schizophrenia in 2 Parts (Part 1 and 2).

Who this might be right for
Schizophrenia
Sumitomo Pharma Co., Ltd. 24
Load More Results